Plain-English translation of NCT06555471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a medication called , which works by helping your immune system fight cancer cells. You would receive it as an infusion every three weeks, combined with chemotherapy pills and radiation therapy directed at your stomach cancer. The goal is to see if this three-part approach works safely and effectively for older adults with locally advanced gastric cancer.
Stomach cancer in older adults is difficult to treat, and current standard treatments may not work well for everyone. Researchers want to know if adding this immune-boosting medication to traditional chemotherapy and radiation can improve outcomes and help more patients.
You likely qualify if…
You likely don't qualify if…
You would receive treatment for about 6–9 weeks combining the medication (given by IV infusion every three weeks), chemotherapy pills taken by mouth for two weeks at a time, and daily radiation therapy five days per week. After the initial treatment phase, you would continue with the medication and chemotherapy pills as maintenance therapy for up to two years. You would have regular check-ups with imaging scans, blood tests, and physical exams—more frequently at first (every 2 months), then every 3 months after the first year—to monitor how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China